The Valley Desk

NCT04506554 · Interventional trial

A Study of Risk Enabled Therapy After Neoadjuvant Immunochemotherapy for Bladder Cancer

Overall registry status Active not recruiting

Phase 2

Conditions Muscle-Invasive Bladder Carcinoma

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov